These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10987126)

  • 1. Aromatic retinoid Ro 40-8757 reduces immunotoxicities of cyclophosphamide as revealed by immunohistochemical staining of lymphoid tissues and general pathologic examinations.
    Inoue T; Horii I
    J Toxicol Sci; 2000 Aug; 25(3):189-98. PubMed ID: 10987126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-tumor arotinoid Ro 40-8757 protects bone marrow from the toxic effects of cyclophosphamide.
    Eliason JF; Inoue T; Kubota A; Teelmann K; Horii I; Hartmann D
    Int J Cancer; 1993 Sep; 55(3):492-7. PubMed ID: 8375933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer.
    Teelmann K; Tsukaguchi T; Klaus M; Eliason JF
    Cancer Res; 1993 May; 53(10 Suppl):2319-25. PubMed ID: 8485719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice.
    Bin-Hafeez B; Ahmad I; Haque R; Raisuddin S
    J Ethnopharmacol; 2001 Apr; 75(1):13-8. PubMed ID: 11282437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative immunotoxicity assessment of N4-Trimethoxybenzoyl-5'-deoxy-5- fluorocytidine (Ro 09-1390) and 5'-deoxy-5-fluorouridine (5'-DFUR) in BDF1 mice.
    Inoue T; Anderson TD; Hayes TJ; Horii I
    J Toxicol Sci; 1996 Feb; 21(1):29-39. PubMed ID: 8852286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levels.
    Fast PE; Hatfield CA; Franz CL; Adams EG; Licht NJ; Merritt MV
    Immunopharmacology; 1982 Dec; 5(2):135-55. PubMed ID: 6761307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relatively low-dose cyclophosphamide is likely to induce apoptotic cell death in rat thymus through Fas/Fas ligand pathway.
    Wang GJ; Cai L
    Mutat Res; 1999 Jun; 427(2):125-33. PubMed ID: 10393266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxicity of the anticancer drug CI-994 in rats: effects on lymphoid tissue.
    Graziano MJ; Galati AJ; Walsh KM
    Arch Toxicol; 1999; 73(3):168-74. PubMed ID: 10401683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative effects of the arotinoid Ro 40-8757 on human cancer cell lines in vitro.
    Eliason JF; Kaufmann F; Tanaka T; Tsukaguchi T
    Br J Cancer; 1993 Jun; 67(6):1293-8. PubMed ID: 8390284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
    Ermak TH; Steger HJ; Wofsy D
    Lab Invest; 1989 Oct; 61(4):447-56. PubMed ID: 2529396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation.
    Van Ewijk W
    Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-tumor arotinoid Ro 40-8757 protects bone marrow from the toxic effects of 5-fluorouracil.
    Eliason JF; Inoue T; Kubota A; Horii I; Hartmann D
    Int J Cancer; 1994 Apr; 57(2):192-7. PubMed ID: 8157357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes.
    Le Gros GS; Prestidge RL; Watson JD
    Immunology; 1983 Dec; 50(4):537-46. PubMed ID: 6606612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytological aspects of rat mammary cancer therapy with soluble tumor-associated antigens and anticancer drugs.
    Zusman I
    Med Sci Monit; 2005 May; 11(5):RA173-181. PubMed ID: 15874908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis.
    Miyauchi A; Hiramine C; Tanaka S; Hojo K
    Tohoku J Exp Med; 1990 Oct; 162(2):147-67. PubMed ID: 2129070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thymus-dependent antigen on recovery of hemo- and lymphopoiesis impaired by antineoplastic drugs.
    Masnaya NV; Ratner GM
    Bull Exp Biol Med; 2000 Jun; 129(6):587-91. PubMed ID: 11022258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric immunotoxicity screening in mice during early drug development.
    Aulí M; Domènech A; Andrés A; Orta M; Salvà M; Descotes J; Prats N
    Toxicol Lett; 2012 Oct; 214(2):200-8. PubMed ID: 22944472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Thy-1, T-200, Lyt-1 and Lyt-2-bearing cells in the developing lymphoid organs of the mouse embryo in vivo and in vitro.
    Van Ewijk W; Jenkinson EJ; Owen JJ
    Eur J Immunol; 1982 Apr; 12(4):262-71. PubMed ID: 6124425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shengqifuzheng Injection promotes the recovery of B cells in gut-associated lymphoid tissues of mice treated with cyclophosphamide].
    Deng X; Huang R; Wen R; Luo X; Zhou L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1073-7. PubMed ID: 27412939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect and anti-lymphatic specificity of a combination of cyclophosphamide and vinblastine on normal lymphopoietic tissues in the mouse].
    Tognella S; Conigliaro S; Scaltrini GC; Recalcati P; Grifoni V
    Haematol Lat; 1970; 13(2):135-44. PubMed ID: 5504039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.